Fiona Crawley has more than 30 years’ experience as a lawyer in private practice advising a wide range of clients.
During her time as a partner in Cambridge based firm, Hewitsons, she was involved in a wide range of start-ups and growing companies, assisting in all aspects of their growth strategy, funding and investment, and exploitation of key intellectual property.In 1999 she moved to the London office of Covington and Burling, a US law firm, where she was able to build on her experience in the pharmaceutical industry, particularly on regulatory issues and working with multinational pharmaceutical companies.From 2002 to June 2013, she was in the London office of Bryan Cave, where she headed the team in London working on IP and commercial contract matters and worked closely with colleagues in the US and elsewhere in Europe.
She sits on the IP Advisory Committee of the BioIndustry Association and has been involved in meetings on behalf of the BIA, following the implementation in the UK of the Nagoya Protocol. Having retired as a solicitor, Fiona now provides corporate and contract services through her Company, for a range of clients, but is particularly interested in helping start ups and SMEs, primarily in the biotechnology, pharmaceuticals and healthcare sector. From 2013 to 2017, Fiona was a non executive Director of Asymptote Limited, a company involved in the development of cryopreservation equipment and services, primarily for the healthcare sector. Asymptote was sold to GE Healthcare in April, 2017.
Fiona assisted Ann Clarke in establishing the Frozen Ark Project and has provided ad hoc contract and other advice over the years, on a pro bono basis.
She became a Trustee in June, 2017.